Exo-AAV- HA-Lhfpl5 injection through RW could partically rescue hearing in Lhfpl5-/- mice (György et al., 2017), thus exo-AAV vectors might provide a new method in gene therapy for treating clinical deafness. This evidence concerns the gene LHFPL5 and deafness.